Wing Ming Ho

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

Winnie Yeo, Paul K.S. Chan, Sheng Zhong et al. · Journal of Medical Virology · 2000 · 628 citations

Medicine, Oncology, Pharmacology +12

A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

Winnie Yeo, Tony Mok, Benny Zee et al. · JNCI Journal of the National Cancer Institute · 2005 · 589 citations · Full text

Medicine, Oncology, Pharmacology +14

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

Winnie Yeo, Benny Zee, Sen Zhong et al. · British Journal of Cancer · 2004 · 313 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

Winnie Yeo, Paul K.S. Chan, Wing Ming Ho et al. · Journal of Clinical Oncology · 2004 · 260 citations · Full text

Medicine, Oncology, Pharmacology +14